health

James Harrison: Verified Profile of the Australian Blood Donor

James Harrison is an Australian man known in public records for his decades of blood donation and a rare physiological trait that has been medically significant. This profile fo...

Mara Ellison
James Harrison: Verified Profile of the Australian Blood Donor

Profile Overview and Key Context

James Harrison is an Australian man known in public records for his decades of blood donation and a rare physiological trait that has been medically significant. This profile focuses on verifiable details documented in widely accessible sources, emphasizing his role in blood banking and the factual context of his contributions. The following content draws from authoritative references, primarily Wikipedia and corroborating public sources, to provide a durable, factual explanation. It answers common questions while clarifying what is confirmed and what remains within public knowledge without speculation.

Background and Early Life

James Harrison was born in 1936 in Australia and grew up in a region where blood donation culture was developing post–World War II. His early life is sparsely documented in mainstream encyclopedic sources, but key biographical anchors are recorded, including his birth year and location. Around age 14, he underwent major chest surgery that involved multiple blood transfusions, an experience that shaped his awareness of blood donation. This personal health event became a motivating factor in his long-term commitment to voluntary donation, illustrating how individual experience can influence public service. These formative details are drawn from biographical summaries that contextualize his later milestones within a broader life narrative.

Medical Context and the Rare Antibody

Harrison’s blood contains rare antibodies that make his plasma medically valuable for producing anti‑D immunoglobulin, which can prevent hemolytic disease of the newborn (HDN) in pregnancies involving RhD-negative women. His immune system consistently produced these antibodies, a trait linked to a past blood transfusion early in life. Medical professionals recognized that his plasma could be used to create lifesaving treatments, leading to extensive testing and eventual large‑scale use. This physiological rarity is not a personal identity but a clinical attribute that has guided his decades-long association with blood banks. Understanding this mechanism helps explain why his donations were systematically collected and why they mattered for public health.

Donation History and Public Service

Over more than 60 years, Harrison is recorded as having donated blood plasma regularly, with estimates often citing more than 1,000 donations. His consistency and the specific medical properties of his blood made him a cornerstone donor program participant, especially in Australia. Blood banks coordinated collections around his health status and eligibility, ensuring a sustainable supply of the rare antibodies. This long-term service transformed individual generosity into a systemic resource, supporting maternity care and reducing HDN incidence. The scale of his contribution is frequently highlighted in profiles of blood donation, illustrating how sustained civic engagement can yield measurable public health benefits.

Milestones and Recognition

  • Around age 14: Underwent major chest surgery requiring multiple blood transfusions, influencing his later commitment to donation.
  • 1950s–1960s: Regular plasma donations began, coinciding with expanded Rh disease prevention programs.
  • 1990s–2000s: Recognized widely in media and health-sector profiles for his cumulative donation milestone.
  • 2018: Officially retired from blood plasma donation at age 81, concluding a documented public service record spanning more than six decades.

Documented Milestones at a Glance

Clinical impact expanded with wider Rh disease prevention
Date or Period Event Why It Matters
1936 Birth year recorded in biographical sources Establishes timeline for lifelong donation span
1950s Began regular plasma donations Marked start of sustained public service contribution
1970s–1980s Plasma used for large‑scale anti‑D production Demonstrated scalability of individual donor impact
1999 Estimated 10,000th donation milestone reported Public recognition of extraordinary consistency
2018 Retired from plasma donation at age 81 Capped a documented record of more than 60 years

Public Perception and Media Portrayal

James Harrison has appeared in documentaries, news features, and human-interest stories that emphasize endurance and civic contribution. Media coverage tends to focus on the volume of his donations and the lives claimed by the anti‑D treatments derived from his plasma. However, encyclopedic entries prioritize verifiable records over emotional framing, noting his role within blood banking rather than personal commentary. Public perception is largely positive, centered on reliability and quiet dedication. This portrayal aligns with broader narratives around voluntary donation systems, where individual stories illustrate institutional impact without reducing complex medical and social factors to a single narrative.

Clarifying Common Misunderstandings

Some sources may exaggerate the uniqueness of Harrison’s antibody or imply that he personally saved a specific number of lives, figures that can be difficult to verify precisely. Encyclopedic entries aim to present ranges and documented outcomes rather than unverified totals. For example, while anti‑D immunoglobulin produced from his plasma has likely prevented HDN in many pregnancies, exact counts are not typically tracked in a way that can be attributed to one donor. Similarly, descriptions of him as the sole or only donor with this trait are generally inaccurate in a statistical sense; his distinction lies in the extraordinary duration and consistency of his donations. Recognizing these nuances helps separate verified information from anecdotal amplification.

Current Status and Lasting Influence

As of the most recent reliable records, James Harrison is retired from blood plasma donation and remains alive, though not frequently in the public spotlight. His retirement in 2018 followed more than six decades of scheduled donations, a timeline that aligns with typical longevity for regular donors subject to medical eligibility reviews. The anti‑D immunoglobulin processes originally informed by his plasma continue to be produced and used, representing a durable public health legacy. While new donors with similar traits contribute to ongoing supplies, Harrison’s historical role is preserved in institutional memory and educational materials. His case remains a reference point in discussions about blood donation policy, rare blood factors, and long-term civic engagement.

Comparative Context

Below is a concise comparison of common attributes associated with James Harrison and typical plasma donors, to clarify what sets his record apart in factual terms.

not found
Attribute James Harrison Typical Regular Plasma Donor
Donation Duration Over 60 years Often a few years
Estimated Donation Count 1,000+ 100–300
Plasma Usage Anti‑D immunoglobulin production General plasma fractions
Recognition Level Public profile in medical case studies and media Usually anonymous within system

Tags

tags: james-harrison, blood-donation, rare-antibody, verified-profile, australia, blood-plasma

Related Reading

More pages in this topic cluster.

Sammi Sweetheart: IVF Journey, Age, Diagnosis, Treatment, and Family Planning Facts

Sammi Sweetheart is a Canadian internet personality who has shared detailed aspects of her fertility experience, including a PCOS diagnosis, multiple rounds of IVF, and the use...

Read next
Can a 13-Year-Old Have a Heart Attack?

Although uncommon, heart attacks can occur in 13-year-olds, usually due to congenital or acquired heart conditions rather than the typical atherosclerotic blockages seen in olde...

Read next
Type 2 Diabetes and Chocolate: How It Affects Blood Sugar and What to Choose

For people with type 2 diabetes, chocolate presents both a flavor opportunity and a metabolic puzzle, because blood sugar management depends on how quickly carbohydrate turns in...

Read next